Table 2.
Model for the Functional Well-Being Subscale of the Functional Assessment of Cancer Therapy–General
| Baseline |
Model A |
Model B |
|
|---|---|---|---|
| Coefficient (SE) | Coefficient (SE) | Coefficient (SE) | |
| Fixed effects | |||
| Baseline | 19.87 (0.91) | 19.87 (0.97)a | 19.87 (0.76)a |
| Uncertainty—T1 | – | – | -0.19 (0.03)a |
| Time 1-time 2 | 1.39 (0.62) | 1.39 (0.62)b | 1.39 (0.62)b |
| Time 2-time 3 | –1.08 (.83) | –1.25 (0.66) | –1.26 (0.66) |
| Uncertainty—T2 | – | –0.20 (0.06)a | –0.16 (0.07)b |
| Variance components | |||
| Level 1: within-person | 6.02 | 6.02 | 5.93 |
| Level 2: baseline | 19.91 | 19.91 | 10.09 |
| Level 2: slope at T2 | 6.14 | 0.65 | 0.52 |
| Deviance (DF) | 486.54 (7) | 473.05 (8) | 457.13 |
| ΔDeviance (df) | – | 13.49 (1), P < .001 | 15.92 (1), P < .000 |
Abbreviation: DF, degrees of freedom.
a
P < .01.
b
P < .05.